Table 2 Correlation between pCR and clinical-pathological data: univariate analysis
No pCR | pCR | Total | |
|---|---|---|---|
Age | |||
< 50 | 44.5% (98) | 55.1% (59) | p = 0.07 |
≥50 | 55.5% (122) | 44.9% (48) | |
Tumor subtypes | |||
HER2+ | 20.5% (45) | 45.3% (48) | p < 0.01 |
HR+/Her2- | 54.5% (120) | 21.7% (23) | |
TNBC | 25% (55) | 33% (35) | |
Grade SBR | |||
II | 51.9% (111) | 34% (36) | p < 0.01 |
III | 48.1% (103) | 66% (70) | |
Clinical stage | |||
I-II | 68.9% (151) | 81.1% (86) | p = 0.02 |
III | 31.1% (68) | 18.9% (20) | |
Vitamin D level | |||
< 20 ng/mL | 45.5% (100) | 33.6% (36) | p = 0.04 |
≥ 20 ng/mL | 54.5% (120) | 66.4% (71) | |